Management, vaccination status and COVID-19 morbidity of patients with Gaucher disease in Germany during the COVID-19 pandemic.

Claus NiederauClaudia RegenbogenHans-Martin FruehaufMartin MerkelAthanasia ZiagakiEugen MengelChristoph BaerwaldNicole MuscholChristian StaufnerChristina LampeAnton GillessenJan Philipp KoehlerStephan Vom Dahl

Published in: Zeitschrift fur Gastroenterologie (2023)

The COVID-19 pandemic has lowered the threshold for switching from practice- or hospital-based ERT to home therapy or to SRT. No major GD complication was documented during the pandemic. Infection rate with SARS-CoV-2 in GD may rather be lower than expected, and its severity is mild. Vaccination rates are high in GD patients and vaccination was well tolerated.

Keyphrases

sars cov
coronavirus disease
end stage renal disease
healthcare
respiratory syndrome coronavirus
chronic kidney disease
ejection fraction
newly diagnosed
primary care
patient reported outcomes
peritoneal dialysis
cell therapy
replacement therapy
mesenchymal stem cells